Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18605811 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
Conditions: Body Weight Change;   Schizophrenia;   Schizoaffective Disorder;   Psychotic Disorder
Intervention: Drug: Aripiprazole

Indicates status has not been verified in more than two years